Assignee
DANA-FARBER CANCER INSTITUTE INC
US·4 granted patents·2 pending applications·16 citations·filing 2013–2019
Top patents by PatentIndex Score
6 records- 0192USRE48175EHydrophobically tagged small molecules as inducers of protein degradationDANA-FARBER CANCER INSTITUTE INC·Filed 2013·Granted Aug 25, 2020·9 cites·25 claims
- 0287US10739333B2Methods of BH3 profilingDANA-FARBER CANCER INSTITUTE INC·Filed 2014·Granted Aug 11, 2020·7 cites·20 claims
- 0363US2020261578A1Glucocorticoid-induced tumor necrosis factor receptor (gitr) antibodies and methods of use thereofDANA-FARBER CANCER INSTITUTE INC·Filed 2019·Application pending·0 cites
- 0460US10738310B2Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitorDANA-FARBER CANCER INSTITUTE INC·Filed 2015·Granted Aug 11, 2020·0 cites·13 claims
- 0552US10745483B2Therapeutic peptidesDANA-FARBER CANCER INSTITUTE INC·Filed 2014·Granted Aug 18, 2020·0 cites·6 claims
- 0630US2020253143A1Iplants of justicia and their usesDANA-FARBER CANCER INSTITUTE INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DANA-FARBER CANCER INSTITUTE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →